GHRP-2

Approved (multiple countries)

Growth Hormone Releasing Peptide-2

Category
Growth Hormone
Aliases
Pralmorelin, KP-102
Administration
Subcutaneous injection

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Increased hunger

Reflects this compound's activity on the same receptor pathway used by the body's natural hunger hormone.

Mild water retention

A modest, temporary increase in fluid retention.

Potential cortisol/prolactin elevation at higher doses

Higher doses may modestly raise stress hormone and prolactin levels, unlike more selective compounds in this class.